ArticleBMC cancer2025

A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study.

Anna Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.